Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Newly-diagnosed Cancers”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableActive Not RecruitingNCT07491211
What this trial is testing

Osimertinib Combined With Intracranial SRT for EGFR-Mutant NSCLC With Symptomatic Brain Metastases

Who this might be right for
NSCLC (Advanced Non-small Cell Lung Cancer)Brain Metastases From Non-small Cell Lung Cancer (NSCLC)Osimertinib+1 more
Fudan University 300
Large-scale testing (Phase 3)UnknownNCT03213977
What this trial is testing

R-DA-EDOCH Versus R-CEOP90, With/Without Upfront Auto-HSCT in Young Patients With High-risk DLBCL

Who this might be right for
Diffuse Large B-cell Lymphoma
Fujian Medical University 475
Large-scale testing (Phase 3)Ended earlyNCT03393000
What this trial is testing

Safety and Efficacy Study of Trans Sodium Crocetinate (TSC) in Newly Diagnosed Glioblastoma (GBM) Biopsy-Only Subjects

Who this might be right for
Glioblastoma
Diffusion Pharmaceuticals Inc 19
Large-scale testing (Phase 3)Looking for participantsNCT06918002
What this trial is testing

Elranatamab/Lenalidomide Consolidation and/or Elranatamab Maintenance Versus Standard of Care After D-VRd Induction in Transplant-eligible NDMM Patients

Who this might be right for
Multiple Myeloma, Newly Diagnosed
Intergroupe Francophone du Myelome 824
Not applicableStudy completedNCT02489357
What this trial is testing

Pembrolizumab and Cryosurgery in Treating Patients With Newly Diagnosed, Oligo-metastatic Prostate Cancer

Who this might be right for
Stage IV Prostate Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 12
Not applicableLooking for participantsNCT06337019
What this trial is testing

The Italian Registry of Malnutrition in Oncology

Who this might be right for
CancerCancer Metastatic
Fondazione IRCCS Policlinico San Matteo di Pavia 1,500
Testing effectiveness (Phase 2)Enrolling By InvitationNCT06773936
What this trial is testing

Adding Asciminib to Usual Treatment for Adults With Newly Diagnosed Philadelphia Chromosome Positive (Ph+) Acute Lymphoblastic Leukemia

Who this might be right for
Philadelphia Chromosome Positive Acute Lymphoblastic LeukemiaCD19+ Acute Leukemia
SWOG Cancer Research Network 55
Early research (Phase 1)Ended earlyNCT04892264
What this trial is testing

Belantamab Mafodotin, Lenalidomide, and Daratumumab for the Treatment of Relapsed, Refractory, or Previously Untreated Multiple Myeloma

Who this might be right for
Plasma Cell MyelomaRecurrent Plasma Cell MyelomaRefractory Plasma Cell Myeloma
Mayo Clinic 5
Large-scale testing (Phase 3)Study completedNCT01190930
What this trial is testing

Risk-Adapted Chemotherapy in Treating Younger Patients With Newly Diagnosed Standard-Risk Acute Lymphoblastic Leukemia or Localized B-Lineage Lymphoblastic Lymphoma

Who this might be right for
Acute Lymphoblastic LeukemiaAdult B Lymphoblastic LymphomaAnn Arbor Stage I B Lymphoblastic Lymphoma+7 more
Children's Oncology Group 9,350
Not applicableStudy completedNCT02208336
What this trial is testing

Electronic Medical Record Review in Monitoring the Effects of Adherence on Myelosuppression and Morbidity in Patients With Newly Diagnosed Brain Tumors Receiving Temozolomide and Radiation Therapy

Who this might be right for
Brain Tumor
Wake Forest University Health Sciences 79
Not applicableEnded earlyNCT00898430
What this trial is testing

Biomarkers in Predicting Response to Treatment in Patients With Newly Diagnosed Stage III or Stage IV Head and Neck Cancer Treated With Carboplatin, Paclitaxel, and Radiation Therapy

Who this might be right for
Head and Neck Cancer
Vanderbilt-Ingram Cancer Center 49
Not applicableLooking for participantsNCT07135271
What this trial is testing

BeSpoke Decision Support for Patients With Newly Diagnosed Localised Prostate Cancer

Who this might be right for
Localised Prostate Cancer
University College, London 346
Testing effectiveness (Phase 2)Study completedNCT01019434
What this trial is testing

Radiation Therapy and Temsirolimus or Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma

Who this might be right for
Brain and Central Nervous System Tumors
European Organisation for Research and Treatment of Cancer - EORTC 111
Testing effectiveness (Phase 2)UnknownNCT04547621
What this trial is testing

HSRT and IMRT Chemoradiotherapy for Newly Diagnosed GBM

Who this might be right for
Glioma, Malignant
Huashan Hospital 50
Testing effectiveness (Phase 2)Study completedNCT00003101
What this trial is testing

Combination Chemotherapy and Bone Marrow Transplantation or Peripheral Stem Cell Transplantation in Treating Patients With Oligodendroglioma

Who this might be right for
Brain and Central Nervous System Tumors
Memorial Sloan Kettering Cancer Center 60
Not applicableLooking for participantsNCT04543201
What this trial is testing

Telehealth Visits to Discuss Advanced Directives for Patients Newly Diagnosed With High Grade Glioma

Who this might be right for
Glioma
University of Rochester 50
Early research (Phase 1)Ended earlyNCT01258634
What this trial is testing

Pre-Operative Treatment of Newly-Diagnosed, Surgically-Resectable Osteosarcoma With Doxorubicin, Ifosfamide, Etoposide, and Cisplatin With Early Metabolic Assessment of Response

Who this might be right for
OsteosarcomaLung Metastases
University of Chicago 2
Not applicableStudy completedNCT02574793
What this trial is testing

Glycemic Fluctuations in Newly Diagnosed Growth Hormone-Secreting Pituitary Adenoma and Cushing Syndrome Subjects

Who this might be right for
Pituitary Adenoma
Huashan Hospital 60
Testing effectiveness (Phase 2)Active Not RecruitingNCT03500445
What this trial is testing

Daratumumab, Carfilzomib, Lenalidomide and Low Dose Dexamethasone (DKRd) in Newly Diagnosed, Multiple Myeloma

Who this might be right for
MyelomaMultiple Myeloma
University of Chicago 75
Testing effectiveness (Phase 2)Active Not RecruitingNCT05520567
What this trial is testing

Gilteritinib, Venetoclax and Azacitidine as a Combined Treatment for People Newly Diagnosed With Acute Myeloid Leukemia

Who this might be right for
Acute Myeloid Leukemia (AML)FLT3-mutated Acute Myeloid Leukemia
Astellas Pharma Global Development, Inc. 70
Next Page